title: Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.
abstract: NhhA (Neisseria hia homologue) is an outer membrane protein from Neisseria meningitidis, the causative agent of meningococcal disease. The protein is surface exposed and its expression in a wide range of meningococcal strains suggests it is a promising vaccine candidate. In addition, immunization of mice with outer membrane vesicles of strains that overexpress NhhA in conjunction with one of TbpA, Omp85 or NspA results in synergistic bactericidal responses. We previously showed that the NhhA sequence is highly conserved between strains, with the majority of the differences localized to four distinct variable regions located in the amino-terminal region of the mature protein. In this study, N. meningitidis strains were constructed that over-express wild-type NhhA. Strains expressing truncated versions of NhhA, with deletions from the amino-terminal region that removed the most variable regions, were also made. These expression strains were also modified so that immunodominant, phase- and antigenically-variable outer membrane proteins were not expressed, truncated lipooligosaccharide (LOS) expression was genetically fixed (no phase variability), and capsular polysaccharide expression abolished. Outer membrane vesicles derived from these strains were used to immunize mice. As previously observed, a synergistic effect involving another antigen, TbpA, was required to demonstrate bactericidal activity. The highest bactericidal response against a heterologous strain was obtained with a truncated variant of NhhA. These results indicate that removal of (a) variable region(s) does not reduce bactericidal responses against NhhA, and that bactericidal targets exist in regions other than the variable N-teminus. This provides the basis for future examination of responses against truncated NhhA in protecting against heterologous NhhA strains, and further evaluation of truncated NhhA as a candidate for inclusion in a vaccine against all serogroups of N. meningitidis.
authors.affiliation: Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
authors.forename: Ian R
authors.initials: IR
authors.lastname: Peak
authors.forename: Yogitha N
authors.initials: YN
authors.lastname: Srikhanta
authors.forename: Vincent E
authors.initials: VE
authors.lastname: Weynants
authors.forename: Christiane
authors.initials: C
authors.lastname: Feron
authors.forename: Jan T
authors.initials: JT
authors.lastname: Poolman
authors.forename: Michael P
authors.initials: MP
authors.lastname: Jennings
mesh_terms: D000818:Animals; D021461:Animals, Outbred Strains; D000907:Antibodies, Bacterial / Q000097:blood; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D008585:Meningitis, Meningococcal / Q000276:immunology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology*; D051379:Mice; D009345:Neisseria meningitidis / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology*; D014611:Vaccination; D064166:Vaccine Potency
chemical_list: D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D022401:Meningococcal Vaccines; D010446:Peptide Fragments
references.citation: Mol Microbiol. 2006 Aug;61(3):631-44
references.pmid: 16803596
references.citation: Expert Rev Vaccines. 2003 Oct;2(5):673-81
references.pmid: 14711328
references.citation: Infect Immun. 2007 Nov;75(11):5434-42
references.pmid: 17664268
references.citation: Lancet. 2002 Apr 27;359(9316):1499-508
references.pmid: 11988262
references.citation: Infect Immun. 1996 Jul;64(7):2745-51
references.pmid: 8698504
references.citation: Nat Biotechnol. 2002 Sep;20(9):914-21
references.pmid: 12172557
references.citation: J Clin Microbiol. 1976 Jul;4(1):71-81
references.pmid: 182717
references.citation: Mol Microbiol. 1995 Nov;18(4):741-54
references.pmid: 8817495
references.citation: J Bacteriol. 2003 Jan;185(1):155-64
references.pmid: 12486052
references.citation: Microb Pathog. 1991 Oct;11(4):249-57
references.pmid: 1813777
references.citation: Mol Microbiol. 2003 Aug;49(3):833-47
references.pmid: 12864863
references.citation: EMBO J. 2000 Nov 15;19(22):5989-99
references.pmid: 11080146
references.citation: Microbes Infect. 2006 Jul;8(8):2145-53
references.pmid: 16797200
references.citation: Infect Immun. 1996 Jan;64(1):298-304
references.pmid: 8557355
references.citation: FEMS Immunol Med Microbiol. 2004 May 1;41(1):43-50
references.pmid: 15094166
references.citation: Vaccine. 2007 Jan 2;25(1):72-84
references.pmid: 16914236
references.citation: Infect Immun. 2012 Nov;80(11):4027-33
references.pmid: 22949555
references.citation: Science. 2000 Mar 10;287(5459):1816-20
references.pmid: 10710308
references.citation: Infect Immun. 2011 Nov;79(11):4308-21
references.pmid: 21844231
references.citation: Mol Microbiol. 1995 Nov;18(4):729-40
references.pmid: 8817494
references.citation: FEMS Immunol Med Microbiol. 2000 Aug;28(4):329-34
references.pmid: 10891657
references.citation: Microbiology (Reading). 2001 Feb;147(Pt 2):250-252
references.pmid: 11158341
references.citation: J Bacteriol. 2000 Nov;182(21):6005-13
references.pmid: 11029419
references.citation: J Struct Biol. 2006 Aug;155(2):154-61
references.pmid: 16675268
references.citation: Mol Microbiol. 1996 Mar;19(6):1215-23
references.pmid: 8730864
references.citation: J Infect Dis. 2004 Oct 15;190(8):1488-97
references.pmid: 15378443
references.citation: J Virol. 2004 Apr;78(8):4029-36
references.pmid: 15047819
references.citation: FEMS Immunol Med Microbiol. 2001 Dec;32(1):53-64
references.pmid: 11750223
references.citation: J Bacteriol. 1996 Nov;178(21):6281-7
references.pmid: 8892830
references.citation: Infect Immun. 2008 Nov;76(11):5412-20
references.pmid: 18794285
references.citation: NIPH Ann. 1991 Dec;14(2):67-79; discussion 79-80
references.pmid: 1812438
references.citation: J Biol Chem. 2004 Apr 9;279(15):14679-85
references.pmid: 14726537
references.citation: Mol Microbiol. 2011 Dec;82(5):1129-49
references.pmid: 22050461